698
S. A. Raw, A. T. Turner / Tetrahedron Letters 50 (2009) 696–699
observed. Also, arylketones are conspicuous by their absence from
the results shown in Table 1, the resonance deactivation of the
carbonyl attenuating their reaction with the relatively unreactive
1-formyl-1-methyl hydrazine under a variety of conditions.
In an effort to address the non-participation of arylketones in
this methodology, we also examined the reaction of substituted
ethyl ynoates 11 with 1-formyl-1-methylhydrazine 7 (Scheme 3).
Disappointingly, though the desired pyrazoles were indeed ob-
tained, the yields were much lower than those seen with b-keto-
esters. It is, however, encouraging that some of the desired
pyrazoles were observed and optimisation of reaction conditions
to allow efficient participation of conjugated alkynes in this type
of chemistry is ongoing within our laboratories, to be reported in
due course.
Acknowledgements
The authors would like to acknowledge Dr. Leigh Ferris (PR & D,
AstraZeneca) and Dr. Barry Hayter (Medicinal Chemistry, AstraZen-
eca) for investigation of Vilsmeier-based approaches to 1.
References and notes
1. (a) For example, Devasagayaraj, A.; Jin, H.; Lui, Q.; Marinelli, B.; Samala, L.; Shi.
Z.-C.; Tunoori, A.; Wang, Y.; Wu, W.; Zhang, C.; Haiming, Z. Int. Patent WO
2007/089335; Chem. Abstr. 2007, 147, 258033.; (b) Boulet, S. L.; Clark, B. P.;
Fairhurst, J.; Gallagher, P. T.; Johansson, A. M.; Whatton, M. A.; Wood, V. A. Int.
Patent WO 2005/092885; Chem. Abstr. 2005, 143, 367217.; (c) Damour, D.;
Hardy, J.-C.; Mignani, S. Int. Patent WO 97/25327; Chem. Abstr. 1997, 127,
176438.; (d) Aloup, J.-C.; Audiau, F.; Barreau, M.; Damour, D.; Genevois-Borella,
A.; Jimonet, P.; Mignani, S.; Ribeill, Y. Int. Patent WO 95/26350; Chem. Abstr.
1995, 124, 146198.
2. (a) For example, Mansfield, D.; Reick, H.; Coqueron, P.-Y.; Desbordes, P.; Villier,
A.; Grosjean-Cournoyer, M.-C.; Genix, P. Int. Patent WO 2006/108791; Chem.
Abstr. 2006, 145, 438609.; (b) Hu, Y.; Xu, B.; Liao, Y.; Nawoschik, K.; Liu, Y.;
Sandrasagra, A.; Fathi, R.; Yang, Z. Int. Patent WO 2006/183751; Chem. Abstr.
2006, 145, 249201.; (c) Ewing, W. R.; Li, J.; Sulsky, R. B.; Hernandez, A. S. U.S.
Patent 2006/079562; Chem. Abstr. 2006, 144, 390925.; (d) Erion, M. D.; Van
Poelje, P. D. U.S. Patent US 6756,360, 2004; Chem. Abstr. 2004, 141, 71536.; (e)
Momose, Y.; Sakai, N.; Maekawa, T.; Hazami, M.; Kawamura, T.; Sera, M. Int.
Patent WO 2004/039365; Chem. Abstr. 2004, 140, 406802.; (f) McKee, T. D.;
Suto, R. K.; Tibbitts, T.; Sowadski, J. Int. Patent WO 2003/074497; Chem. Abstr.
2003, 139, 286330.; (g) Bohme, A.; Boireau, A.; Canton, T.; Pratt, J., Stultzman,
J.-M. Int. Patent WO 2000/054772; Chem. Abstr. 2000, 133, 247292.
3. (a) Park, M.-S.; Park, H.-J.; Park, K. H.; Lee, K.-I. Synth. Commun. 2004, 34, 1541–
1550; (b) Ishii, T.; Tomitani, K.; Shimotori, H.; Tanaka, Y.; Ishikawa, K. Japanese
Patent 01-168674, 1989; Chem. Abstr. 1989, 112, 35853.; (c) Ishii, T.; Tomitani,
K.; Shimotori, H.; Tanaka, Y.; Ishikawa, K. Japanese Patent 01-168673, 1989;
Chem. Abstr. 1989, 112, 35852.; (d) Ishii, T.; Tomitani, K.; Shimotori, H.; Tanaka,
Y.; Ishikawa, K. Japanese Patent 01-168672, 1989; Chem. Abstr. 1989, 112,
35851.; (e) Wijnberger, C.; Habraken, C. L. J. Heterocycl. Chem. 1969, 6, 545.
4. (a) Hishiwaki, N.; Matsushima, K.; Chatani, M.; Tamura, M.; Ariga, M. Synlett
2004, 703–707; (b) Yamamoto, S.; Morimoto, K.; Sato, T. J. Heterocycl. Chem.
1991, 28, 1545–1547; (c) Menozzi, G.; Mosti, L.; Schenone, P. J. Heterocycl.
Chem. 1987, 24, 1669–1675; (d) Huppatz, J. L. Aust. J. Chem. 1983, 36,
135–147; (e) Bajnati, A.; Hubert-Habart, M. Bull. Soc. Chim. Fr. 1988, 3, 540–
547.
H
H2N
N
Me
O
R
CO2Et
CO2Et
H
7
EtOH
Reflux
EtONa
Reflux
R
N
+
N
Me
N
O
N
R
CO2Et
Me
11a R=Me
11b R=Ph
2 R=Me, 18%
R=Ph, 8%
Scheme 3.
Finally, we have also demonstrated that ester 2 can indeed be
converted easily to the target aldehyde 1 (Scheme 4). As shown,
simple functional group interconversion gave access first to the
alcohol 3, then to aldehyde 1 in good yields. For our purposes,
these steps were telescoped into a single stage, which gave 1 in
78% overall yield.13
5. Press, J. B.; Eudy, N. H.; Morton, G. O. J. Org. Chem. 1983, 48, 4605–4611.
6. We found some precedence for this type of cyclisation in the production of
pyrazolo[1,5-a]indole and quinoline systems, in which the N-carbonyl and
N-alkyl substituents of the hydrazone are contained in a cyclic motif, see:
Winters, G.; Odasso, G.; Conti, M.; Tarzia, G.; Galliani, G. Eur. J. Med. Chem. 1984,
19, 215–218; A similar mechanism has also been implicated in the production
of a minor pyrazolo[5,1,a]indole by-product, see: Toja, E.; Omodei-Sale, A.;
Nathansohn, G. Tetrahedron Lett. 1979, 31, 2921–2924.
O
Me
Me
O
OH
N
N
2 M LiAlH4 in THF
THF, RT
N
Me
3
N
7. Pedersen, C. T. Acta Chem. Scand. 1964, 18, 2199–2200.
8. Kost, A. N.; Grandberg, I. I. Adv. Heterocycl. Chem. 1966, 6, 347–429.
9. For example, see: Heller, S. T.; Natarajan, S. R. Org. Lett. 2006, 8, 2675. It should
be noted that, even in this methodology, the use of methylhydrazine gives poor
regioselectivity at best.
Me
2
88%, 87% (w/w)
10. Typical laboratory-scale procedure for 2: To a cooled solution (0–5 °C) of
methylhydrazine (660 mmol, 35.0 mL) in IMS (215 mL) was added ethyl
formate (688 mmol, 55.5 mL) dropwise so that the temperature remained
below 10 °C. Once the addition was complete, the solution was heated to reflux
for 4 h. To the colourless solution was then added ethyl acetoacetate
(550 mmol, 70.0 mL) and reflux continued for a further 4 h. The resulting
MnO2,THF,
reflux
H
Me
O
yellow solution was cooled to ꢀ55 °C and
a solution of 21 wt % sodium
Telescope (ref. 13)
78%, 99% (w/w)
ethoxide in IMS (550 mmol, 205.4 mL) was added dropwise so that a gentle
reflux was maintained. Once addition was complete, reflux was maintained for
45 min. The suspension was then cooled to rt and diluted with 3 M ammonium
chloride (360 mL) and brine (360 mL). The resulting solution was extracted
with MTBE (2 Â 360 and 1 Â 180 mL). The combined organics were washed
with saturated brine (180 mL) diluted with water (180 mL). The MTBE solution
was concentrated by distillation to ꢀ400 mL, then n-heptane (1200 mL) was
added. Distillation was continued until the head temperature was constant at
97–99 °C and the volume in the vessel was 380 mL. The solution was allowed
to cool to ambient temperature, then in an ice/water bath to 3–5 °C. The
precipitated solid was collected by filtration, washed with cold n-heptane
(2 Â 80 mL) and dried in vacuo at ambient temperature to give the desired
pyrazole ester 2 (38.32 g, 98 wt %, 223 mmol, 41% yield), as an off-white
crystalline solid. The spectroscopic data for this material match those reported,
see Ref. 4c.
N
N
Me
1
93%, 98% (w/w)
Scheme 4.
In summary, we have developed a robust 3-step, 1-stage pro-
cess for the synthesis of 1,3,4-trisubstituted-1H-pyrazoles which
exploits a novel C4–C5 disconnection strategy and readily available
raw materials. The chemistry is operationally simple and obviates
the need to employ Vilsmeier-type chemistry. To demonstrate its
synthetic utility, this methodology has been successfully applied
to produce a range of pyrazoles (Table 1).
11. Acid 10 has been shown to undergo the reduction–oxidation chemistry applied
to ester 2 equally well.
12. All compounds gave satisfactory spectroscopic data.
13. Typical laboratory-scale procedure for 1: To a solution of pyrazole ester 2
(204 mmol, 35.0 g) in THF (209 mL) at 0–3 °C was added a solution of 2.0 M
LiAlH4 in THF (204 mmol, 102 mL) dropwise so that the temperature remained
below 10 °C. Once the addition was complete, the mixture was stirred at 0–3 °C